《一氧化氮前体和二甲基精氨酸作为一般人群中测量的肾小球滤过率加速下降的风险标志物》勘误[第8卷，第4期，2023年4月，第818 - 826页]
Corrigendum to "Nitric Oxide Precursors and Dimethylarginines as Risk Markers for Accelerated Measured GFR Decline in the General Population" [ Volume 8, Issue 4, April 2023, Pages 818-826].
作者信息
Rinde Nikoline B, Enoksen Inger Therese, Melsom Toralf, Fuskevåg Ole Martin, Eriksen Bjørn Odvar, Norvik Jon Viljar
机构信息
Metabolic and Renal Research Group, UiT The Arctic University of Norway, Tromsø, Norway.
Section of Nephrology, University Hospital of North Norway, Tromsø, Norway.
出版信息
Kidney Int Rep. 2024 May 6;9(7):2311-2312. doi: 10.1016/j.ekir.2024.05.001. eCollection 2024 Jul.
Abstract
[This corrects the article DOI: 10.1016/j.ekir.2023.01.015.].
摘要
[本文更正了文章的数字对象标识符：10.1016/j.ekir.2023.01.015。]
相似文献
1
Corrigendum to "Nitric Oxide Precursors and Dimethylarginines as Risk Markers for Accelerated Measured GFR Decline in the General Population" [ Volume 8, Issue 4, April 2023, Pages 818-826].《一氧化氮前体和二甲基精氨酸作为一般人群中测量的肾小球滤过率加速下降的风险标志物》勘误[第8卷，第4期，2023年4月，第818 - 826页]
Kidney Int Rep. 2024 May 6;9(7):2311-2312. doi: 10.1016/j.ekir.2024.05.001. eCollection 2024 Jul.
2
Corrigendum to "The Association Between Metabolic Syndrome, Hyperfiltration, and Long-Term GFR Decline in the General Population" [ Volume 8, Issue 9, September 2023, Pages 1831-1840].《普通人群中代谢综合征、高滤过与长期肾小球滤过率下降之间的关联》勘误[第8卷，第9期，2023年9月，第1831 - 1840页]
Kidney Int Rep. 2024 May 6;9(7):2312. doi: 10.1016/j.ekir.2024.05.002. eCollection 2024 Jul.
3
Corrigendum to "Atypical Clinical Presentation of Autosomal Recessive Polycystic Kidney Mimicking Medullary Sponge Kidney Disease" [ Volume 7, Issue 4, April 2022, Pages 916-919].《模仿髓质海绵肾疾病的常染色体隐性多囊肾的非典型临床表现》勘误 [第7卷，第4期，2022年4月，第916 - 919页]
Kidney Int Rep. 2024 Jun 10;9(8):2584. doi: 10.1016/j.ekir.2024.06.015. eCollection 2024 Aug.
4
Corrigendum to "Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis" [ Volume 9, Issue 4, April 2024, Pages 1047-1056].《狼疮性肾炎患者持续临床缓解对狼疮发作风险及肾功能损害的影响》勘误[第9卷，第4期，2024年4月，第1047 - 1056页]
Kidney Int Rep. 2024 Feb 24;9(4):1143. doi: 10.1016/j.ekir.2024.02.1399. eCollection 2024 Apr.
5
Corrigendum to "Detecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease"Kidney International Reports, Volume 7, Issue 4, April 2022, Pages 857-866.《对“在经临床病理诊断患有常染色体显性遗传性肾小管间质性肾病的患者中检测MUC1变异体”的勘误》，《国际肾脏报告》，第7卷，第4期，2022年4月，第857 - 866页
Kidney Int Rep. 2023 Mar 13;8(5):1127-1129. doi: 10.1016/j.ekir.2023.02.1090. eCollection 2023 May.
6
Corrigendum to "Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy" [ Volume 6, Issue 4, April 2021, Pages 1183-1188].《“PLA2R1 相关膜性肾病中利妥昔单抗耐药性的分析与管理”的勘误》[第 6 卷，第 4 期，2021 年 4 月，第 1183 - 1188 页]
Kidney Int Rep. 2024 May 23;9(7):2313. doi: 10.1016/j.ekir.2024.05.020. eCollection 2024 Jul.
7
Corrigendum to "WCN24-1709 NON-CADAVERIC HOMOLOGOUS VEIN AS VASCULAR ACCESS IN A PATIENT WITH EXHAUSTED NATIVE VEINS ON HEMODIALYSIS" [ Volume 9, Issue 4, Supplement, April 2024, Pages S398-S399].《“WCN24 - 1709 非尸体同源静脉作为血液透析时自身静脉耗竭患者的血管通路”勘误》[第9卷，第4期，增刊，2024年4月，第S398 - S399页]
Kidney Int Rep. 2024 Jun 3;9(8):2580. doi: 10.1016/j.ekir.2024.05.035. eCollection 2024 Aug.
8
Corrigendum to "WCN24-1924 SOCIODEMOGRAPHIC AND CLINICAL PROFILE OF OLDER ADULTS IN A HEMODIALYSIS UNIT IN NORTHEASTERN BRAZIL: CHALLENGES AND PERSPECTIVES" [ Volume 9, Issue 4, Supplement, April 2024, Pages S282-S283].《巴西东北部一家血液透析单位老年患者的社会人口学和临床特征：挑战与展望》勘误 [第9卷，第4期，增刊，2024年4月，第S282 - S283页]
Kidney Int Rep. 2024 Jun 6;9(8):2582. doi: 10.1016/j.ekir.2024.06.006. eCollection 2024 Aug.
9
Corrigendum to "WCN24-2221 NEPHROCALCINOSIS AND LOWER LIMBS TISSUE NECROSIS DUE TO CALCIUM OXALATE DEPOSITS IN A 24-YEAR-OLD PATIENT WITH STAGE 5 CHRONIC KIDNEY DISEASE" [ Volume 9, Issue 4, Supplement, April 2024, Pages S656-S657].《“WCN24 - 2221：一名24岁5期慢性肾脏病患者因草酸钙沉积导致肾钙质沉着症和下肢组织坏死”勘误》[第9卷，第4期，增刊，2024年4月，第S656 - S657页]
Kidney Int Rep. 2024 Apr 18;9(6):1937. doi: 10.1016/j.ekir.2024.04.038. eCollection 2024 Jun.
10
Corrigendum to "WCN24-786 PHASE I DOSE ESCALATION STUDY OF SHR6508, A CALCIUM-SENSING RECEPTOR AGONIST, IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM" [ Volume 9, Issue 4, Supplement, April 2024, Pages S368-S369].《“WCN24 - 786：钙敏感受体激动剂SHR6508在继发性甲状旁腺功能亢进血液透析患者中的I期剂量递增研究”勘误》[第9卷，第4期，增刊，2024年4月，第S368 - S369页]
Kidney Int Rep. 2024 Jun 6;9(8):2579-2580. doi: 10.1016/j.ekir.2024.06.005. eCollection 2024 Aug.
Zotero 插件